knowledge -WSS

knowledge

author：comprehensive 2025-09-29 03:49:06 - browse：8

Dr. Laurie Glimcher, CEO of Dana Farber Cancer Institute, opens both arms while talking — coverage from STAT — Laurie Glimcher, CEO of Dana Farber Cancer Institute, is the architect of the biggest shakeup in Boston health care in decades. David L. Ryan/Globe Staff

Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in science was built on a basic principle: Big discoveries require big risks.

The younger Glimcher took that advice to heart. In the late 1990s at her Harvard immunology lab, Glimcher and her postdoctoral student began a series of experiments that colleagues deemed “crazy.” But after a year of trial and error, the lab had a eureka moment when it found that white blood cells could be reprogrammed, a seminal discovery that led to new ways to treat cancer.

“Most scientists do good work, but they don’t transform a scientific question,” said Glimcher. “I always felt the only way to do that is to think big and go after something that’s going to be really important.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： The Readout: Gilead, Bernie Sanders, and other pharma news

focus

WSS

Vaccine advisory panel ACIP left half staffed by HHS

PhRMA lawsuit over Medicare drug price negotiation tossed

Biogen Alzheimer’s drug launch off to slow start

Medicare threatens to cut off funding for HCA's Mission hospital

Radiology is caught between AI's potential and concern for patients

Biogen Alzheimer’s drug launch off to slow start

knowledge

knowledge

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

Leukemia patients are helped by Syndax's new type of therapy

Hollywood unions extend contract negotiations for actors

Pfizer plans to depart BIO

Medical leaders decry Supreme Court decision on affirmative action

Senators start work on Medicare physician payment reform

DIEP, the 'gold standard' of breast reconstruction, is under threat

For Medicare Advantage, Democrats want stronger protections around AI

Medicare details structure of new drug price negotiation program

Radiology is caught between AI's potential and concern for patients

Wikipedia

Medical mystery: When a cough is not just a cough

KalVista pill reduced swelling 'attacks' caused by genetic disease

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Patients' immediate access to test results puts radiologists in a bind

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

The woman behind the Dana Farber

hotspot

hotspot

focus

entertainment